FDA Inspection 1165895 — Novo Nordisk A/S

Novo Nordisk A/S — FEI 3000151819

The FDA completed an inspection of Novo Nordisk A/S on Dec 5, 2019 in Bagsvard. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 5, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bagsvard (Denmark)

Additional Details

Mutual Recognition Agreement (MRA)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.